{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:59:09Z","timestamp":1776279549974,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in the <jats:italic>BRCA2<\/jats:italic> gene are associated with sporadic and familial cancer, cause genomic instability and sensitize cancer cells to inhibition by the poly(ADP-ribose) polymerase (PARP). Here we show that human pluripotent stem cells (hPSCs) with one copy of <jats:italic>BRCA2<\/jats:italic> deleted can be used to annotate variants of this gene and to test their sensitivities to PARP inhibition. By using Cas9 to edit the functional <jats:italic>BRCA2<\/jats:italic> allele in the locally haploid hPSCs and in fibroblasts differentiated from them, we characterized essential regions in the gene to identify permissive and loss-of-function mutations. We also used Cas9 to directly test the function of individual amino acids, including amino acids encoded by clinical <jats:italic>BRCA2<\/jats:italic> variants of uncertain significance, and identified alleles that are sensitive to PARP inhibitors used as a standard of care in <jats:italic>BRCA2<\/jats:italic>-deficient cancers. Locally haploid human pluripotent stem cells can facilitate detailed structure\u2013function analyses of genes and the rapid functional evaluation of clinically observed mutations.<\/jats:p>","DOI":"10.1038\/s41551-023-01065-7","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T16:01:51Z","timestamp":1690214511000},"page":"165-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Hanqin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Bartke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-2707","authenticated-orcid":false,"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Horacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Rechav Ben-Natan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella R.","family":"Pangilinan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Netravathi","family":"Krishnappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-6591","authenticated-orcid":false,"given":"Rasmus","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-5092","authenticated-orcid":false,"given":"Dirk","family":"Hockemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King, M. C., Marks, J. H. & Mandell, J. B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643\u2013646 (2003).","journal-title":"Science"},{"key":"1065_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913\u2013917 (2005).","journal-title":"Nature"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord, C. J. & Ashworth, A. PARP inhibitors: synthetic lethality in the clinic. Science 355, 1152\u20131158 (2017).","journal-title":"Science"},{"key":"1065_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature03556","volume":"435","author":"FD Urnov","year":"2005","unstructured":"Urnov, F. D. et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646\u2013651 (2005).","journal-title":"Nature"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nbt.1562","volume":"27","author":"D Hockemeyer","year":"2009","unstructured":"Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851\u2013857 (2009).","journal-title":"Nat. Biotechnol."},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"1065_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"1065_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"1065_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"1065_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR\u2013Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"1065_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","volume":"562","author":"GM Findlay","year":"2018","unstructured":"Findlay, G. M. et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature 562, 217\u2013222 (2018).","journal-title":"Nature"},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2021.01.012","volume":"184","author":"RE Hanna","year":"2021","unstructured":"Hanna, R. E. et al. Massively parallel assessment of human variants with base editor screens. Cell 184, 1064\u20131080.e20 (2021).","journal-title":"Cell"},{"key":"1065_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41587-021-01201-1","volume":"40","author":"S Erwood","year":"2022","unstructured":"Erwood, S. et al. Saturation variant interpretation using CRISPR prime editing. Nat. Biotechnol. 40, 885\u2013895 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1065_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich, S. E. et al. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019).","journal-title":"Genome Med."},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"1065_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0698-7","volume":"11","author":"H Gelman","year":"2019","unstructured":"Gelman, H. et al. Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation. Genome Med. 11, 85 (2019).","journal-title":"Genome Med."},{"key":"1065_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ng1092-128","volume":"2","author":"SA Smith","year":"1992","unstructured":"Smith, S. A., Easton, D. F., Evans, D. G. & Ponder, B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 2, 128\u2013131 (1992).","journal-title":"Nat. Genet."},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.7939630","volume":"266","author":"PA Futreal","year":"1994","unstructured":"Futreal, P. A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120\u2013122 (1994).","journal-title":"Science"},{"key":"1065_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.1178955","volume":"326","author":"JE Carette","year":"2009","unstructured":"Carette, J. E. et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326, 1231\u20131235 (2009).","journal-title":"Science"},{"key":"1065_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature17408","volume":"532","author":"I Sagi","year":"2016","unstructured":"Sagi, I. et al. Derivation and differentiation of haploid human embryonic stem cells. Nature 532, 107\u2013111 (2016).","journal-title":"Nature"},{"key":"1065_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41556-018-0088-1","volume":"20","author":"A Yilmaz","year":"2018","unstructured":"Yilmaz, A., Peretz, M., Aharony, A., Sagi, I. & Benvenisty, N. Defining essential genes for human pluripotent stem cells by CRISPR\u2013Cas9 screening in haploid cells. Nat. Cell Biol. 20, 610\u2013619 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1065_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrg.2017.75","volume":"19","author":"I Bartha","year":"2018","unstructured":"Bartha, I., di Iulio, J., Venter, J. C. & Telenti, A. Human gene essentiality. Nat. Rev. Genet. 19, 51\u201362 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1065_CR24","doi-asserted-by":"publisher","first-page":"e79208","DOI":"10.7554\/eLife.79208","volume":"11","author":"H Li","year":"2022","unstructured":"Li, H. et al. Highly efficient generation of isogenic pluripotent stem cell models using prime editing. eLife 11, e79208 (2022).","journal-title":"eLife"},{"key":"1065_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nature03404","volume":"434","author":"F Esashi","year":"2005","unstructured":"Esashi, F. et al. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434, 598\u2013604 (2005).","journal-title":"Nature"},{"key":"1065_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2011","unstructured":"Roy, R., Chun, J. & Powell, S. N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 12, 68\u201378 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"1065_CR27","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","volume":"297","author":"H Yang","year":"2002","unstructured":"Yang, H. et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297, 1837\u20131848 (2002).","journal-title":"Science"},{"key":"1065_CR28","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop, K. et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J. Clin. Oncol. 30, 2654\u20132663 (2012).","journal-title":"J. Clin. Oncol."},{"key":"1065_CR29","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1158\/0008-5472.CAN-07-6189","volume":"68","author":"T Hucl","year":"2008","unstructured":"Hucl, T. et al. A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 68, 5023\u20135030 (2008).","journal-title":"Cancer Res."},{"key":"1065_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm.1719","volume":"14","author":"SG Kuznetsov","year":"2008","unstructured":"Kuznetsov, S. G., Liu, P. & Sharan, S. K. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat. Med. 14, 875\u2013881 (2008).","journal-title":"Nat. Med."},{"key":"1065_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1399-0004.2006.00698.x","volume":"70","author":"H Naseem","year":"2006","unstructured":"Naseem, H. et al. Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes. Clin. Genet. 70, 388\u2013395 (2006).","journal-title":"Clin. Genet."},{"key":"1065_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/jmedgenet-2015-103206","volume":"52","author":"JE Higgs","year":"2015","unstructured":"Higgs, J. E. et al. The BRCA2 polymorphic stop codon: stuff or nonsense? J. Med. Genet. 52, 642\u2013645 (2015).","journal-title":"J. Med. Genet."},{"key":"1065_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng1196-253","volume":"14","author":"S Mazoyer","year":"1996","unstructured":"Mazoyer, S. et al. A polymorphic stop codon in BRCA2. Nat. Genet. 14, 253\u2013254 (1996).","journal-title":"Nat. Genet."},{"key":"1065_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cancers13030447","volume":"13","author":"S Baughan","year":"2021","unstructured":"Baughan, S. & Tainsky, M. A. K3326X and other C-terminal BRCA2 variants implicated in hereditary cancer syndromes: a review. Cancers 13, 447 (2021).","journal-title":"Cancers"},{"key":"1065_CR35","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013d1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1065_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"1065_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171\u2013182 (2002).","journal-title":"Cell"},{"key":"1065_CR38","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck, T. R. et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313, 1347\u20131361 (2015).","journal-title":"JAMA"},{"key":"1065_CR39","doi-asserted-by":"publisher","first-page":"13241","DOI":"10.1038\/ncomms13241","volume":"7","author":"EM Kass","year":"2016","unstructured":"Kass, E. M., Lim, P. X., Helgadottir, H. R., Moynahan, M. E. & Jasin, M. Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation. Nat. Commun. 7, 13241 (2016).","journal-title":"Nat. Commun."},{"key":"1065_CR40","first-page":"3441","volume":"58","author":"M Morimatsu","year":"1998","unstructured":"Morimatsu, M., Donoho, G. & Hasty, P. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. Cancer Res. 58, 3441\u20133447 (1998).","journal-title":"Cancer Res."},{"key":"1065_CR41","first-page":"990","volume":"62","author":"KA McAllister","year":"2002","unstructured":"McAllister, K. A. et al. Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res. 62, 990\u2013994 (2002).","journal-title":"Cancer Res."},{"key":"1065_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1128\/MCB.18.1.93","volume":"18","author":"B Elliott","year":"1998","unstructured":"Elliott, B., Richardson, C., Winderbaum, J., Nickoloff, J. A. & Jasin, M. Gene conversion tracts from double-strand break repair in mammalian cells. Mol. Cell. Biol. 18, 93\u2013101 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"1065_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia, B. et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22, 719\u2013729 (2006).","journal-title":"Mol. Cell"},{"key":"1065_CR44","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-16-2568","volume":"77","author":"H Shimelis","year":"2017","unstructured":"Shimelis, H. et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 77, 2789\u20132799 (2017).","journal-title":"Cancer Res."},{"key":"1065_CR45","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1101\/gad.13.20.2633","volume":"13","author":"AJ Pierce","year":"1999","unstructured":"Pierce, A. J., Johnson, R. D., Thompson, L. H. & Jasin, M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13, 2633\u20132638 (1999).","journal-title":"Genes Dev."},{"key":"1065_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nbt.3235","volume":"33","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Discovery of cancer drug targets by CRISPR\u2013Cas9 screening of protein domains. Nat. Biotechnol. 33, 661\u2013667 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1065_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/386804a0","volume":"386","author":"SK Sharan","year":"1997","unstructured":"Sharan, S. K. et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804\u2013810 (1997).","journal-title":"Nature"},{"key":"1065_CR48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR\u2013Cas system. Cell 163, 759\u2013771 (2015).","journal-title":"Cell"},{"key":"1065_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR\u2013Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"1065_CR50","first-page":"119","volume":"2","author":"FR Kreitzer","year":"2013","unstructured":"Kreitzer, F. R. et al. A robust method to derive functional neural crest cells from human pluripotent stem cells. Am. J. Stem Cells 2, 119\u2013131 (2013).","journal-title":"Am. J. Stem Cells"},{"key":"1065_CR51","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2010.04.010","volume":"141","author":"CJ Lengner","year":"2010","unstructured":"Lengner, C. J. et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141, 872\u2013883 (2010).","journal-title":"Cell"},{"key":"1065_CR52","doi-asserted-by":"publisher","first-page":"21312","DOI":"10.1074\/jbc.M114.564625","volume":"289","author":"MC Canver","year":"2014","unstructured":"Canver, M. C. et al. Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)\/Cas9 nuclease system in mammalian cells. J. Biol. Chem. 289, 21312\u201321324 (2014).","journal-title":"J. Biol. Chem."},{"key":"1065_CR53","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.stemcr.2016.07.021","volume":"7","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Efficient CRISPR\/Cas9-mediated versatile, predictable, and donor-free gene knockout in human pluripotent stem cells. Stem Cell Rep. 7, 496\u2013507 (2016).","journal-title":"Stem Cell Rep."},{"key":"1065_CR54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2144\/000114196","volume":"57","author":"Q Zheng","year":"2014","unstructured":"Zheng, Q. et al. Precise gene deletion and replacement using the CRISPR\/Cas9 system in human cells. BioTechniques 57, 115\u2013124 (2014).","journal-title":"BioTechniques"},{"key":"1065_CR55","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nbt.3715","volume":"34","author":"S Zhu","year":"2016","unstructured":"Zhu, S. et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat. Biotechnol. 34, 1279\u20131286 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1065_CR56","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1065_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17, 148 (2016).","journal-title":"Genome Biol."},{"key":"1065_CR58","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01065-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:03:11Z","timestamp":1708473791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01065-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1038\/s41551-023-01065-7","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"29 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A provisional patent application, filed in the United States by University of California, has D.H., H.L. and R.B. as inventors. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}